1. Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors. (6th March 2021) Authors: Fujiwara, Yutaka; Kenmotsu, Hirotsugu; Yamamoto, Noboru; Shimizu, Toshio; Yonemori, Kan; Ocampo, Christopher; Parikh, Apurvasena; Okubo, Sumiko; Fukasawa, Kazuteru; Murakami, Haruyasu Journal: Cancer medicine Issue: Volume 10:Number 7(2021) Page Start: 2350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer. (September 2019) Authors: Udagawa, Hibiki; Akamatsu, Hiroaki; Tanaka, Kentaro; Takeda, Masayuki; Kanda, Shintaro; Kirita, Keisuke; Teraoka, Shunsuke; Nakagawa, Kazuhiko; Fujiwara, Yutaka; Yasuda, Ikuko; Okubo, Sumiko; Shintani, Masayuki; Kosloski, Matthew P.; Scripture, Charity; Tamura, Tomohide; Okamoto, Isamu Journal: Lung cancer Issue: Volume 135(2019) Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Venetoclax in combination with azacitidine in Japanese patients with acute myeloid leukaemia: phase 1 trial findings. (13th March 2021) Authors: Taniguchi, Shuichi; Yamauchi, Takahiro; Choi, Ilseung; Fukuhara, Noriko; Potluri, Jalaja; Salem, Ahmed Hamed; Hong, Wan-Jen; Honda, Hideyuki; Nishimura, Yasuko; Okubo, Sumiko; Usuki, Kensuke Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 6(2021) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy. (5th November 2021) Authors: Yamamoto, Kazuhito; Shinagawa, Atsushi; DiNardo, Courtney D; Pratz, Keith W; Ishizawa, Kenichi; Miyamoto, Toshihiro; Komatsu, Norio; Nakashima, Yasuhiro; Yoshida, Chikashi; Fukuhara, Noriko; Usuki, Kensuke; Yamauchi, Takahiro; Asada, Noboru; Asou, Norio; Choi, Ilseung; Miyazaki, Yasushi; Honda, H... Journal: Japanese journal of clinical oncology Issue: Volume 52:Number 1(2022) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy. (29th July 2021) Authors: Yamauchi, Takahiro; Yoshida, Chikashi; Usuki, Kensuke; Takada, Satoru; Matsumura, Itaru; Dobashi, Nobuaki; Miyazaki, Yasushi; Miyamoto, Toshihiro; Iida, Hiroatsu; Asou, Norio; Kuroda, Junya; Ichikawa, Satoshi; Komatsu, Norio; Mendes, Wellington; Honda, Hideyuki; Okubo, Sumiko; Kurokawa, Misaki; J... Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 9(2021) Page Start: 1372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗